Sort

Search

01/12/2024 Newborn Screening for Sickle Cell Disease in Catalonia between 2015 and 2022-Epidemiology and Impact on Clinical Events
de Aledo-Castillo, JMG, Argudo-Ramírez, A, Beneitez-Pastor, D, Collado-Gimbert, A, Castro, FA, Roig-Bosch, S, Andres-Masó, A, Ruiz-Llobet, A, Pedrals-Portabella, G, Medina-Santamaria, D, Nadal-Rey, G, Espigares-Salvia, M, Coll-Sibina, MT, Algar-Serrano, M, Torrent-Español, M, Leoz-Allegretti, P, Rodríguez-Pebé, A, García-Bernal, M, Solà-Segura, E, García-Gallego, A, Prats-Viedma, B, López-Galera, RM, Paredes-Fuentes, AJ, García, SP, Delgado-López, G, Blanco-alvarez, A, Tazón-Vega, B, de Heredia, CD, Mañu-Pereira, MD, Marin-Soria, JL, García-Villoria, J, Velasco-Puyo, P. Newborn Screening for Sickle Cell Disease in Catalonia between 2015 and 2022-Epidemiology and Impact on Clinical Events. International Journal Of Neonatal Screening. 2024; 10(4)DOI:10.3390/ijns10040069. PMID:39449357. IF:(Q/D).
01/12/2024 Ten take-home messages on vasopressin use in critically ill patients
Ferrer, R, Castro, P, Lorencio, C, Monclou, J, Marcos-Neira, P, Ochagavía, A, Ruíz-Rodríguez, JC, Trenado, J, Villavicencio, C, Yébenes, JC, Zapata, L. Ten take-home messages on vasopressin use in critically ill patients. Medicina Intensiva. 2024; 48(12)DOI:10.1016/j.medin.2024.07.008. PMID:39438184. IF:3.100(Q2/3D).
01/12/2024 Position of the Ibero-American Society of Neurourology and Urogynecology (SINUG) on the urodynamics (UDS) in women undergoing surgical treatment for stress urinary incontinence (SUI)
Medina-Polo, J, Arlandis-Guzmán, S, Martínez-García, R, Padilla-Fernández, B, Castro-Díaz, D, Cruz, F, Errando-Smet, C, Espuña-Pons, M, González-Enguita, C, López-Fando, L, Martín-Martínez, A, Martínez-Cuenca, E, Montes-Posada, I, Müller-Arteaga, C, Muñoz-Menéndez, AB, Ramírez-García, I, Ros, C, Blasco-Hernández, P. Position of the Ibero-American Society of Neurourology and Urogynecology (SINUG) on the urodynamics (UDS) in women undergoing surgical treatment for stress urinary incontinence (SUI). Continence. 2024; 12DOI:10.1016/j.cont.2024.101714. PMID:. IF:(Q/D).
01/12/2024 Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non-muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk Dynamics
Subiela, JD, Krajewski, W, González-Padilla, DA, Laszkiewicz, J, Taborda, J, Aumatell, J, Encinas, MS, Basile, G, Moschini, M, Caño-Velascof, J, Perez, EL, Duran, PD, Galliolig, A, Tukiendorf, A, D'Andreaj, D, Teoh, JYC, Céspedes, AS, Pichler, R, Afferi, L, Del Giudice, F, Rivas, JG, Albisinni, S, Soria, F, Ploussard, G, Mertens, LS, Rajwa, P, Laukhtinaj, E, Praderej, B, Tully, K, Guerrero-Ramos, F, Rodríguez-Faba, O, Alvarez-Maestro, M, Dominguez-Escrig, JL, Szydelko, T, Dos Santos, VG, Cidre, MAJ, Revilla, FJB. Unlocking the Potential of Adequate Bacillus Calmette-Guérin Immunotherapy in Very-high-risk Non-muscle-invasive Bladder Carcinoma: A Multicenter Analysis of Oncological Outcomes and Risk Dynamics. European Urology Oncology. 2024; 7(6)DOI:10.1016/j.euo.2024.01.017. PMID:38355375. IF:9.300(Q1/1D).